Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CurQ+
- Development stage
- Preclinical
- Lead developer
- Stratum Nutrition
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
**CurQ+** is a branded, orally administered high-bioavailability curcumin dietary-supplement ingredient developed by ESM Technologies and marketed through Stratum Nutrition. It combines 95% curcumin with a proprietary coconut-oil and polysorbate 20 dispersion system intended to improve gastrointestinal absorption of curcumin. CurQ+ has been evaluated in healthy-volunteer bioavailability studies and is being studied in an exercise-recovery setting; preclinical and case-report literature has also described its potential use in pseudoachondroplasia. ([stratumnutrition.com](https://stratumnutrition.com/human/ingredients/detail/curQplus/overview))
- Brand names
- BIOCURCCurQ+
- Other names
- curQplus
02
Targets
Mechanistic target of rapamycin complex 1TNFA (Tumor necrosis factor alpha (soluble))IL10 (Interleukin-10)IL-6 (Interleukin 6)IL1B (Interleukin-1 beta)
Beyond the preview
Go deeper on CurQ+.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CurQ+.